Filmed on location in New York during the Great Debates & Updates in Hematologic Malignancies 2015, this webcast is part of a series that focuses on controversial areas in the management of hematologic malignancies as nationally-recognized thought leaders take opposing sides on topics of clinical interest.
In this presentation, Dr. Ruben Niesvizky argues that quadruplet regimens are the ideal induction therapy for newly-diagnosed, transplant-eligible myeloma patients.
© 2015 Imedex, LLC.
